WallStSmart

MKS Instruments Inc (MKSI)vsSynopsys Inc (SNPS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Synopsys Inc generates 113% more annual revenue ($8.68B vs $4.07B). SNPS leads profitability with a 8.9% profit margin vs 8.0%. MKSI appears more attractively valued with a PEG of 1.32. MKSI earns a higher WallStSmart Score of 61/100 (C+).

MKSI

Buy

61

out of 100

Grade: C+

Growth: 7.3Profit: 6.5Value: 3.3Quality: 5.0
Piotroski: 4/9Altman Z: 1.24

SNPS

Hold

45

out of 100

Grade: D+

Growth: 6.7Profit: 5.0Value: 3.0Quality: 4.5
Piotroski: 1/9Altman Z: 1.48
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MKSISignificantly Overvalued (-75.4%)

Margin of Safety

-75.4%

Fair Value

$147.68

Current Price

$301.65

$153.97 premium

UndervaluedFair: $147.68Overvalued

Intrinsic value data unavailable for SNPS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MKSI2 strengths · Avg: 9.0/10
EPS GrowthGrowth
53.2%10/10

Earnings expanding 53.2% YoY

Revenue GrowthGrowth
15.2%8/10

15.2% revenue growth

SNPS3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
41.9%10/10

Revenue surging 41.9% year-over-year

Market CapQuality
$97.34B9/10

Large-cap with strong market position

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Areas to Watch

MKSI2 concerns · Avg: 2.0/10
P/E RatioValuation
74.6x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.242/10

Distress zone — elevated risk

SNPS4 concerns · Avg: 2.5/10
Return on EquityProfitability
2.5%3/10

ROE of 2.5% — below average capital efficiency

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
3.022/10

Expensive relative to growth rate

P/E RatioValuation
116.1x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : MKSI

The strongest argument for MKSI centers on EPS Growth, Revenue Growth. Revenue growth of 15.2% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bull Case : SNPS

The strongest argument for SNPS centers on Revenue Growth, Market Cap, Price/Book. Revenue growth of 41.9% demonstrates continued momentum.

Bear Case : MKSI

The primary concerns for MKSI are P/E Ratio, Altman Z-Score. A P/E of 74.6x leaves little room for execution misses.

Bear Case : SNPS

The primary concerns for SNPS are Return on Equity, Piotroski F-Score, PEG Ratio. A P/E of 116.1x leaves little room for execution misses.

Key Dynamics to Monitor

MKSI profiles as a growth stock while SNPS is a hypergrowth play — different risk/reward profiles.

MKSI carries more volatility with a beta of 2.00 — expect wider price swings.

SNPS is growing revenue faster at 41.9% — sustainability is the question.

SNPS generates stronger free cash flow (617M), providing more financial flexibility.

Bottom Line

MKSI scores higher overall (61/100 vs 45/100) and 15.2% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MKS Instruments Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.

Visit Website →

Synopsys Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Synopsys is an American electronic design automation company that focuses on silicon design and verification, silicon intellectual property and software security and quality. Products include logic synthesis, behavioral synthesis, place and route, static timing analysis, formal verification, hardware description language (SystemC, SystemVerilog/Verilog, VHDL) simulators, and transistor-level circuit simulation.

Visit Website →

Want to dig deeper into these stocks?